Asuragen Inc - Product Pipeline Analysis, 2017 Update

Summary

Asuragen Inc (Asuragen) is a provider of laboratory medicine solutions. The company offers products which include amplidex, quantidex, and custom reagents. It offers custom and companion diagnostic services which include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. The companys custom reagents comprise armored reagents, in vitro transcribed RNA and plasmid DNA kits. It distributes its products in Algeria, Australia, Austria, Belgium, Brazil, Bulgaria, Denmark, Egypt, Germany, Iceland, India, the UAE, the UK and the US, among others. Asuragen is headquartered in Austin, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Asuragen Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Asuragen Inc Company Overview 4
Asuragen Inc Company Snapshot 4
Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Asuragen Inc Pipeline Analysis Overview 7
Asuragen Inc - Key Facts 7
Asuragen Inc - Major Products and Services 8
Asuragen Inc Pipeline Products by Development Stage 9
Asuragen Inc Pipeline Products Overview 11
Diagnostic Test - Neurodegenerative Disorders 11
Diagnostic Test - Neurodegenerative Disorders Product Overview 11
miRNA Based Sequencing Test - Esophageal Cancer 12
miRNA Based Sequencing Test - Esophageal Cancer Product Overview 12
miRNA Based Sequencing Test - Colon Cancer 13
miRNA Based Sequencing Test - Colon Cancer Product Overview 13
miRNA Based Sequencing Test - Lung Cancer 14
miRNA Based Sequencing Test - Lung Cancer Product Overview 14
miRNA Based Sequencing Test - Pancreatic Cancer 15
miRNA Based Sequencing Test - Pancreatic Cancer Product Overview 15
Signature CF Expand 16
Signature CF Expand Product Overview 16
Asuragen Inc - Key Competitors 17
Asuragen Inc - Key Employees 18
Asuragen Inc - Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Asuragen Inc, Recent Developments 20
Apr 25, 2017: Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio 20
Mar 14, 2017: Asuragen Launches the AmplideX PCR/CE TOMM40 Kit Expanding Portfolio into the Alzheimers and Cognitive Impairment Space 20
Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit 20
Aug 09, 2016: Asuragen Develops Armored RNA Quant Zika Virus Control 21
Jul 25, 2016: Asuragens QuantideX qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance For Monitoring Minimal Residual Disease In Chronic Myeloid Leukemia 22
Jul 06, 2016: Asuragen Launches the AmplideX PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia 22
Apr 18, 2016: Asuragen to Present Expansion of Next-Generation Sequencing Portfolio at American Association for Cancer Research Annual Meeting 23
Nov 05, 2015: Asuragen Launches Amplidex PCR/CE FMR1 Reporter, A Fully Automated Software Solution For Accurate Sizing Of The FMR1 CGG Repeat Region 23
Jul 08, 2015: Asuragen Launches the Quantidex Pan Cancer Kit, a Workflow Solution for Targeted Next-Generation Sequencing 24
Jun 11, 2015: Asuragen Announces Launch of Highly Sensitive CE-IVD BCR-ABL Assay at the European Hematology Association Annual Congress 25
Appendix 26
Methodology 26
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Asuragen Inc Pipeline Products by Equipment Type 5
Asuragen Inc Pipeline Products by Indication 6
Asuragen Inc, Key Facts 7
Asuragen Inc, Major Products and Services 8
Asuragen Inc Number of Pipeline Products by Development Stage 9
Asuragen Inc Pipeline Products Summary by Development Stage 10
Diagnostic Test - Neurodegenerative Disorders - Product Status 11
Diagnostic Test - Neurodegenerative Disorders - Product Description 11
miRNA Based Sequencing Test - Esophageal Cancer - Product Status 12
miRNA Based Sequencing Test - Esophageal Cancer - Product Description 12
miRNA Based Sequencing Test - Colon Cancer - Product Status 13
miRNA Based Sequencing Test - Colon Cancer - Product Description 13
miRNA Based Sequencing Test - Lung Cancer - Product Status 14
miRNA Based Sequencing Test - Lung Cancer - Product Description 14
miRNA Based Sequencing Test - Pancreatic Cancer - Product Status 15
miRNA Based Sequencing Test - Pancreatic Cancer - Product Description 15
Signature CF Expand - Product Status 16
Signature CF Expand - Product Description 16
Asuragen Inc, Key Employees 18
Glossary 27

List Of Figures


Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23

Asuragen Inc - Product Pipeline Analysis, 2017 Update

Asuragen Inc (Asuragen) is a provider of laboratory medicine solutions. The company offers products which include amplidex, quantidex, and custom reagents. It offers custom and companion diagnostic services which include

USD 750 View Report

Asuragen Inc - Medical Equipment - Deals and Alliances Profile

Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that provides laboratory medicine solutions. The company offers products such as amplidex, quantidex, and custom reagents. It provides custom and companion

USD 250 View Report

Consolidated Edison Company of New York Inc - Strategic SWOT Analysis Review

Consolidated Edison Company of New York Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a

USD 125 View Report

Armada Hoffler Properties Inc - Strategy, SWOT and Corporate Finance Report

Armada Hoffler Properties Inc - Strategy, SWOT and Corporate Finance Report market research report available in single user pdf license with Aarkstore Enterprise at USD 175

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available